Literature DB >> 21052530

Modulation of gene expression in endothelial cells by hyperlipaemic postprandial serum from healthy volunteers.

Nicolas Dejeans, Jeanette A M Maier, Igor Tauveron, Dragan Milenkovic, Andrzej Mazur.   

Abstract

UNLABELLED: A single high-fat challenge induces plasmatic pro-inflammatory and pro-oxidative responses in the postprandial state, even in healthy men. This period is also associated with vascular endothelial dysfunction, which is an early event in the development of cardiovascular diseases. However, knowledge about the mechanisms involved in postprandial hyperlipaemia-induced endothelial dysfunction is sparse. An objective of our study was to characterize the behaviour and gene expression of vascular endothelial cells exposed to postprandial hyperlipaemic sera. Human umbilical vein endothelial cells (HUVECs) were cultured in media containing 10% serum from healthy men withdrawn either before or 4 h after a high-fat challenge. Endothelial cell proliferation, adhesion and migration were then assessed. The transcriptomic profiles of endothelial cells exposed to pre and postprandial sera were also compared. Exposure to postprandial hyperlipaemic sera significantly decreased HUVEC proliferation when compared to preprandial serum (P < 0.0001), while no changes in migration or endothelial/monocyte interactions were observed. The transcriptomic analysis revealed changes in the expression of 675 genes, of which 431 have a known function. Among them, a set of differentially expressed genes was linked to cell cycle regulation and apoptosis and are regulated in favour of cell cycle arrest or death. This result was confirmed by measuring the induction of apoptosis after postprandial sera exposure (P = 0.011). Taken together, the transcriptomic results and pathway analysis showed that postprandial serum promotes apoptosis in HUVECs, potentially through the activation of the p53 network. We conclude that upon postprandial serum exposure, vascular endothelial cells transcriptionally regulate genes involved in the control of cell cycle and death to favour growth arrest and apoptosis. These findings support the hypothesis that postprandial hyperlipaemia is associated with vascular dysfunction and offer new insights into the mechanisms involved. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12263-010-0166-x) contains supplementary material, which is available to authorized users.

Entities:  

Keywords:  Apoptosis atherogenesis; Nutrigenomics; Postprandial hyperlipaemia; Vascular endothelial cells

Year:  2010        PMID: 21052530      PMCID: PMC2935529          DOI: 10.1007/s12263-010-0166-x

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  45 in total

1.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

Review 2.  Differential gene expression profiling in genetic and multifactorial cardiovascular diseases.

Authors:  Luisa Nanni; Chiara Romualdi; Attilio Maseri; Gerolamo Lanfranchi
Journal:  J Mol Cell Cardiol       Date:  2006-10-03       Impact factor: 5.000

3.  Identification of genes potentially involved in rupture of human atherosclerotic plaques.

Authors:  B C Faber; K B Cleutjens; R L Niessen; P L Aarts; W Boon; A S Greenberg; P J Kitslaar; J H Tordoir; M J Daemen
Journal:  Circ Res       Date:  2001-09-14       Impact factor: 17.367

4.  Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.

Authors:  Francesco Nappo; Katherine Esposito; Michele Cioffi; Giovanni Giugliano; Anna Maria Molinari; Giuseppe Paolisso; Raffaele Marfella; Dario Giugliano
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

Review 5.  ATP-Binding cassette cholesterol transporters and cardiovascular disease.

Authors:  John F Oram; Ashley M Vaughan
Journal:  Circ Res       Date:  2006-11-10       Impact factor: 17.367

6.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 7.  Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis?

Authors:  S Dimmeler; C Hermann; A M Zeiher
Journal:  Eur Cytokine Netw       Date:  1998-12       Impact factor: 2.737

Review 8.  Cytochrome P450--physiological key factor against cholesterol accumulation and the atherosclerotic vascular process.

Authors:  Pauli V Luoma
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

Review 9.  The p53 response: emerging levels of co-factor complexity.

Authors:  Amanda S Coutts; Nicholas B La Thangue
Journal:  Biochem Biophys Res Commun       Date:  2005-06-10       Impact factor: 3.575

10.  BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments.

Authors:  Fátima Al-Shahrour; Pablo Minguez; Juan M Vaquerizas; Lucía Conde; Joaquín Dopazo
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

View more
  3 in total

1.  Model-based clustering of multi-tissue gene expression data.

Authors:  Pau Erola; Johan L M Björkegren; Tom Michoel
Journal:  Bioinformatics       Date:  2020-03-01       Impact factor: 6.937

Review 2.  Molecular mechanisms underlying some major common risk factors of stroke.

Authors:  Reem Alkahtani
Journal:  Heliyon       Date:  2022-08-18

3.  Gene Expression, Oxidative Stress, and Senescence of Primary Coronary Endothelial Cells Exposed to Postprandial Serum of Healthy Adult and Elderly Volunteers after Oven-Cooked Meat Meals.

Authors:  Costarelli Laura; Giacconi Robertina; Francesco Piacenza; Andrea Basso; Deborah Pacetti; Michele Balzano; Riccardo Gagliardi; Natale Giuseppe Frega; Eugenio Mocchegiani; Mauro Provinciali; Marco Malavolta
Journal:  Mediators Inflamm       Date:  2017-12-12       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.